La biología y el tratamiento de la ceguera con células madre
Des cellulles souches pour soigner la vision
Restoring vision with stem cells
Intellectual property
STEMAXON's cumulative IP, starting with the only proven human sporadic AD model (PCT) and AD-cascade related compounds (PCT) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.
STEMAXON's Legal partners are Fasken Martineau.
In the News:
FOLLOW US ON LINKEDIN
STEMAXON is a Canadian biotechnology company located in Montréal which specializes in stem cell technology.
STEMAXON to validate the technology of iPSC differentiation into photoreceptor cells for cell therapy applications
Stem Cell Advance Brings Vision Repair in Sight
ADVANCED RESEARCH FOR LIFE
El trasplante de fotorreceptores llega para curar la degeneración macular
The Biology of Treating Blindness with Stem Cells
MEMBER OF BIOQUÉBEC
STEMAXON has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''
FOR ALL THE LATEST NEWS, PLEASE VISIT OUR LINKEDIN PAGE
Stem Cells: Regeneration Methods for the Visual System